Read + Share
Amedeo Smart
Independent Medical Education
Wollenberg A, Beck LA, Blauvelt A, Simpson EL, et al. Assessing the need for routine safety testing for patients being treated with dupilumab for moderate-to-severe atopic dermatitis. Br J Dermatol 2020;182:e186-e209.PMID: 32476149
Email
LinkedIn
Facebook
Twitter
Privacy Policy